Marban Linda has filed 13 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 7500 shares of CAPRICOR THERAPEUTICS, INC. ($CAPR) on January 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Restricted Stock Units | 7500 | $0.00 | 7,500.0000 | 45,716,151 | 9999.99% | 0.02% |
| Jan. 5, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 45,716,151 | 9999.99% | 0.22% |
| Jan. 5, 2026 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 45,716,151 | 9999.99% | 0.11% |
| March 3, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | M | Common Stock | 25000 | $1.39 | 223,604.0000 | 35,218,628 | 12.59% | 0.07% |
| March 5, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | J | Common Stock | 12500 | $0.00 | 211,104.0000 | 35,218,628 | 5.59% | 0.04% |
| March 3, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 35,218,628 | 100.00% | 0.07% |
| Jan. 2, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 210000 | $0.00 | 210,000.0000 | 35,218,628 | 9999.99% | 0.60% |
| Jan. 2, 2025 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 34962 | $0.00 | 34,962.0000 | 35,218,628 | 9999.99% | 0.10% |
| Jan. 2, 2024 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 9633 | $0.00 | 9,633.0000 | 26,778,360 | 9999.99% | 0.04% |
| Jan. 2, 2024 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 26,778,360 | 9999.99% | 0.93% |
| May 12, 2023 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | M | Common Stock | 20749 | $1.39 | 198,604.0000 | 25,247,354 | 11.67% | 0.08% |
| May 12, 2023 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | M | Stock Option (Right to Buy) | 41497 | $0.00 | 0.0000 | 25,247,354 | 100.00% | 0.16% |
| Jan. 3, 2023 | CAPRICOR THERAPEUTICS, INC. | $CAPR | Marban Linda | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 24,552,688 | 9999.99% | 0.55% |